Investigation of the Effects of H-PRF on the Period After Impacted Third Molar Tooth Extraction
Launched by ESENGUL SEN · Jan 29, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Many studies have been conducted in the literature to minimize these situations encountered after tooth extraction. Various regenerative methods are being developed to reduce these complaints of patients. Regenerative treatments include non-steroidal anti-inflammatory drugs (NSAIDs), laser therapy, steroids, ultrasound, and PRF applications.
PRF(platelet-rich fibrin) application placed in the extraction socket is one of the regenerative methods used to reduce these complaints. PRF has a fibrin structure obtained from natural blood tissue, containing abundant platelets and leukocytes. This ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer ASA I individuals between the ages of 18-40
- Exclusion Criteria:
- • Those who are pregnant or lactating
- • Those receiving anticoagulant or antiplatelet drug therapy
- • Those who received radiotherapy to the head and face area
- • Those who are allergic to local anesthetics and prescribed medications
About Esengul Sen
Esengul Sen is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. With a commitment to improving patient outcomes, Esengul Sen collaborates with leading healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. The organization prioritizes ethical standards and regulatory compliance, ensuring that all trials are designed to generate reliable data that can contribute to the advancement of medical science. Through its strategic partnerships and commitment to excellence, Esengul Sen aims to bring transformative treatments to market that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tokat, Kaleardı Neighbourhood, Turkey
Tokat, , Turkey
Patients applied
Trial Officials
Esengül ŞEN
Study Director
Tokat Gaziosmanpasa University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported